These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33554086)

  • 1. Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study.
    Dommasch M; Steger A; Barthel P; Huster KM; Müller A; Sinnecker D; Laugwitz KL; Penzel T; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri HV; Bauer A; Malik M; Zabel M; Schmidt G;
    EClinicalMedicine; 2021 Jan; 31():100695. PubMed ID: 33554086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
    Bauer A; Klemm M; Rizas KD; Hamm W; von Stülpnagel L; Dommasch M; Steger A; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri H; Malik M; Schmidt G; Zabel M;
    Lancet; 2019 Oct; 394(10206):1344-1351. PubMed ID: 31488371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study.
    Zabel M; Willems R; Lubinski A; Bauer A; Brugada J; Conen D; Flevari P; Hasenfuß G; Svetlosak M; Huikuri HV; Malik M; Pavlović N; Schmidt G; Sritharan R; Schlögl S; Szavits-Nossan J; Traykov V; Tuinenburg AE; Willich SN; Harden M; Friede T; Svendsen JH; Sticherling C; Merkely B;
    Eur Heart J; 2020 Sep; 41(36):3437-3447. PubMed ID: 32372094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project.
    Zabel M; Schlögl S; Lubinski A; Svendsen JH; Bauer A; Arbelo E; Brusich S; Conen D; Cygankiewicz I; Dommasch M; Flevari P; Galuszka J; Hansen J; Hasenfuß G; Hatala R; Huikuri HV; Kenttä T; Kucejko T; Haarmann H; Harden M; Iovev S; Kääb S; Kaliska G; Katsimardos A; Kasprzak JD; Qavoq D; Lüthje L; Malik M; Novotný T; Pavlović N; Perge P; Röver C; Schmidt G; Shalganov T; Sritharan R; Svetlosak M; Sallo Z; Szavits-Nossan J; Traykov V; Vandenberk B; Velchev V; Vos MA; Willich SN; Friede T; Willems R; Merkely B; Sticherling C;
    J Electrocardiol; 2019; 57S():S34-S39. PubMed ID: 31526572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation.
    Zabel M; Sticherling C; Willems R; Lubinski A; Bauer A; Bergau L; Braunschweig F; Brugada J; Brusich S; Conen D; Cygankiewicz I; Flevari P; Taborsky M; Hansen J; Hasenfuß G; Hatala R; Huikuri HV; Iovev S; Kääb S; Kaliska G; Kasprzak JD; Lüthje L; Malik M; Novotny T; Pavlović N; Schmidt G; Shalganov T; Sritharan R; Schlögl S; Szavits Nossan J; Traykov V; Tuinenburg AE; Velchev V; Vos MA; Willich SN; Friede T; Svendsen JH; Merkely B;
    ESC Heart Fail; 2019 Feb; 6(1):182-193. PubMed ID: 30299600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICD risk stratification studies - EU-CERT-ICD and the European perspective.
    Seegers J; Bergau L; Tichelbäcker T; Malik M; Zabel M
    J Electrocardiol; 2016; 49(6):831-836. PubMed ID: 27623399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
    Boas R; Sappler N; von Stülpnagel L; Klemm M; Dixen U; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Tfelt-Hansen J; Bauer A; Rizas KD
    Circulation; 2022 Mar; 145(10):754-764. PubMed ID: 34889650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
    Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators.
    Junttila MJ; Pelli A; Kenttä TV; Friede T; Willems R; Bergau L; Malik M; Vandenberk B; Vos MA; Schmidt G; Merkely B; Lubinski A; Svetlosak M; Braunschweig F; Harden M; Zabel M; Huikuri HV; Sticherling C;
    Diabetes Care; 2020 Jan; 43(1):196-200. PubMed ID: 31645407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.
    Marynissen T; Floré V; Heidbuchel H; Nuyens D; Ector J; Willems R
    Europace; 2014 Jul; 16(7):1069-77. PubMed ID: 24196450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.
    Al-Khatib SM; Hellkamp AS; Fonarow GC; Mark DB; Curtis LH; Hernandez AF; Anstrom KJ; Peterson ED; Sanders GD; Al-Khalidi HR; Hammill BG; Heidenreich PA; Hammill SC
    JAMA; 2014 Jun; 311(21):2209-15. PubMed ID: 24893088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing ICD-resistant mortality as an end point to evaluate the clinical efficacy of an implantable cardioverter-defibrillator in ischaemic cardiomyopathy.
    Floré V; Vandenberk B; Belmans A; Garweg C; Ector J; Willems R
    Acta Cardiol; 2018 Feb; 73(1):19-27. PubMed ID: 28685657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
    Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
    Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.